29/06/2022 - 17:45 Financial Report of the Annual and Special General Shareholders’ Meeting - Approval of a gross dividend of EUR 2.60 per share in the form of an optional dividend Weiterlesen
29/06/2022 - 07:30 Financial Gimv - Modalités du dividende optionnel Apport du droit au dividende net en échange de la souscription d'une nouvelle action à 45,50 euros ou 25 droits au dividende relatifs à l’exercice 2021/2022 Weiterlesen
15/06/2022 - 07:30 Portfolio Gimv strengthens its position in life sciences venture capital with the creation of a new dedicated platform Weiterlesen
14/06/2022 - 13:55 ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline Weiterlesen
09/06/2022 - 07:30 Portfolio Gimv takes a significant interest in Picot, an industrial group active in the production of gates & fencing and provider of fencing solutions Weiterlesen
07/06/2022 - 07:30 Portfolio Gimv co-leads CHF 71M (USD 74M) Series B financing in ImmunOs Therapeutics to develop novel therapies in oncology and autoimmune disease. Weiterlesen
25/05/2022 - 17:00 Finanziell Convocation of the annual general meeting of Gimv on June 29th, 2022 Weiterlesen
24/05/2022 - 07:30 Portfolio Gimv investiert erneut in Industrieautomatisierung und wird Mehrheitseigner des Werkstückträgerspezialisten Variotech Weiterlesen
19/05/2022 - 06:58 Finanziell Beeindruckende Wachstumsleistung unserer Portfolio-Unternehmen führt zu starkem Ergebnis Weiterlesen
18/05/2022 - 07:25 Portfolio Gimv invests in Variass, a specialized developer and producer of electronic and mechatronic products and systems Weiterlesen
26/04/2022 - 08:15 Portfolio Die KÖBERL Group wächst weiter mit dem Erwerb von KRIOTEC und erweitert ihr Leistungsspektrum um Kühl-, Kälte- und Klimatechnik Weiterlesen
22/04/2022 - 07:00 Portfolio Gimv invests in BioConnection, a contract development and manufacturing organisation for injectable (bio)pharmaceutical products Weiterlesen
07/04/2022 - 07:30 Portfolio Gimv announces the creation of Olyn group, leader in omnichannel customer engagement Weiterlesen
16/03/2022 - 08:00 Portfolio Precirix raises EUR 80m in Series B, Gimv further supports the development of precision radiopharmaceuticals Weiterlesen
10/03/2022 - 07:30 Portfolio Gimv sells stake in the Wolf Lingerie Group, the owner of Sans Complexe, the fourth largest brand in the French market Weiterlesen
03/03/2022 - 07:30 Portfolio Bessere Versorgung in der ambulanten Reha: Gimv-Portfolio-unternehmen rehaneo übernimmt Reha Vita Weiterlesen
16/02/2022 - 07:30 Finanziell Gimv announces share buyback in the context of a share purchase plan for its personnel Weiterlesen
07/02/2022 - 07:30 Portfolio Biolam, the French group of medical laboratories, accelerates Weiterlesen
27/01/2022 - 07:30 Portfolio Gimv acquires GSDI Group, the European leader in surface treatment and adhesive film application, to support its next stage of growth Weiterlesen
25/01/2022 - 07:00 Portfolio Biotalys Achieves Breakthrough in Protein Expression Increasing Commercial Potential for its first BioFungicide Evoca Weiterlesen
